USPTO serial 79199028
DEWELLOP
Reviewed by CopyMark Law Group
Reg. 5283226Status 709
- Filing date
- Status date
- Registration date
- Sep 12, 2017
- Examiner
- HOPKINS II, DEAN ANDREW
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with DEWELLOP?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
John C. McElwaine
John C. McElwaine Nelson Mullins Riley & Scarborough LLP100 North Tryon Street42nd Floor, IP DepartmentCharlotte, NC 28202Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Antioxidant pills; dietetic foods adapted for medical purposes; dietetic beverages adapted for medical purposes; digestives for pharmaceutical purposes; drugs for medical purposes, namely, medicines for treatment of gastrointestinal diseases, treatment of tumors, including treatment during and after tumor surgery, and treatment during and after neurosurgery; gauze for dressings; gases for medical purposes; adhesive plasters for medical purposes; sticking plasters for medical purposes; adhesive tapes for medical purposes; adhesive bands for medical purposes; candy for medical purposes; chewing gum for medical purposes; medicinal herbal extracts for medical purposes, namely, decoctions for pharmaceutical purposes; medicinal tea; mineral food supplements; surgical cloth tissues, namely, dressings for wounds, medicated compresses used during surgery; hemostatics for medical purposes; hemorrhoid preparations; medicines for alleviating constipation; vitamin preparations; pharmaceutical preparations, namely, for treating gastrointestinal diseases, treating diabetes, and cancer | SECTION 71 - CANCELLED | — |
| 010 | Diagnostic apparatus for medical purposes, namely, for the detection of cancer, tumors, and gastrointestinal diseases; clips, surgical; filters for ultraviolet rays, for medical purposes; gastroscopes; UV lamps, lamps for use with medical instruments, fluorescent lamps, and infrared lamps for medical purposes; medical apparatus and instruments, namely, medical apparatus and instruments for use in surgery and anesthesia; medical guidewires; needles for medical purposes; probes for medical purposes; surgical apparatus and instruments; suture needles; suture materials; testing apparatus for medical purposes, namely, testing of cancer tumors, and gastrointestinal diseases; apparatus for use in medical analysis, namely, for use in anesthesia, for monitoring cardiac output, oxygenation, and muscle relaxation during surgery; surgical drapes; catheters | SECTION 71 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Developeration AB
- Other trademarks owned by Developeration AB
- Other trademarks owned by Developeration AB
- Other trademarks in Class 005
- Other trademarks in Class 010
- Similar marks named DEWELLOP
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jan 24, 2025 | INNT | TOTAL INVALIDATION PROCESSED BY THE IB | — |
| Jan 4, 2025 | INTS | TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB | — |
| Jan 4, 2025 | INPC | INVALIDATION PROCESSED | — |
| Nov 30, 2024 | INTR | TOTAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Mar 29, 2024 | C71T | CANCELLED SECTION 71 | — |
| Jun 4, 2023 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Sep 12, 2022 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Jan 26, 2018 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Dec 16, 2017 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Dec 16, 2017 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Dec 12, 2017 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Sep 12, 2017 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jun 27, 2017 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jun 27, 2017 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jun 7, 2017 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| May 23, 2017 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| May 10, 2017 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| May 10, 2017 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| May 10, 2017 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| May 10, 2017 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| May 10, 2017 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Apr 25, 2017 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Apr 25, 2017 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Apr 25, 2017 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Apr 25, 2017 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Apr 14, 2017 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Apr 14, 2017 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 13, 2017 | ALIE | ASSIGNED TO LIE | — |
| Mar 30, 2017 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Feb 3, 2017 | RFNT | REFUSAL PROCESSED BY IB | — |
| Jan 17, 2017 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jan 17, 2017 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jan 11, 2017 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jan 10, 2017 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 7, 2017 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jan 3, 2017 | DOCK | ASSIGNED TO EXAMINER | — |
| Jan 3, 2017 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Dec 29, 2016 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |